Skip to main content

Table 1 Risk of second cancer by age

From: Impact of race and tumor subtype on second malignancy risk in women with breast cancer

Under 50 50 and older
  Observed O/E Excess risk Mean age at event Observed O/E Excess risk Mean age at event
All sites 16,492 1.64# 43.06 54.64 58,378 1.10# 15.01 74.42
All solid tumors 15,479 1.68# 41.91 54.48 52,829 1.13# 17.32 74.2
Oral cavity and pharynx 204 1.25# 0.27 55.68 915 1.04 0.11 74.1
Digestive system 1481 1.07# 0.61 59.52 11,942 0.98 −0.6 77.01
Colon, rectum and anus 808 0.94 −0.36 59.13 7569 0.98 −0.34 77.15
Pancreas 237 1.22# 0.28 60.83 1734 0.95# −0.28 77.03
Peritoneum, omentum and mesentery 45 2.04# 0.15 59.65 110 0.94 −0.02 74.85
Respiratory system 1555 1.28# 2.29 59.76 7790 0.97# −0.78 74.11
Bones and joints 25 2.01# 0.08 53.86 50 1.1 0.01 72.67
Soft tissue including heart 110 2.14# 0.39 54.64 334 1.39# 0.27 74.43
Skin excluding basal and squamous 525 1.21# 0.61 54.16 1604 1.12# 0.48 74.49
Breast 8696 2.37# 33.49 52.44 19,175 1.36# 14.45 72.76
Female genital system 1877 1.35# 3.21 54.84 6909 1.19# 3.17 73.36
Corpus and uterus, NOS 903 1.21# 1.05 56.38 4262 1.36# 3.26 73.25
Ovary 720 1.99# 2.39 53.05 1785 1.07# 0.32 72.97
Urinary system 469 1.14# 0.4 59.24 2997 1.04 0.29 75.86
Brain and other nervous system 120 1.06 0.04 54.58 395 0.75# −0.37 72.7
Endocrine system 429 1.25# 0.57 52.14 806 1.28# 0.51 69.21
Lymphoma 361 0.94 −0.16 58.64 2145 0.91# −0.63 76.54
Leukemia 352 1.90# 1.11 53.62 1551 1.08# 0.31 75.51
  1. # Indicates P value <0.05